Shandong Lukang PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 3/6
Shandong Lukang PharmaceuticalLtd has a total shareholder equity of CN¥4.0B and total debt of CN¥2.8B, which brings its debt-to-equity ratio to 69.5%. Its total assets and total liabilities are CN¥9.2B and CN¥5.1B respectively. Shandong Lukang PharmaceuticalLtd's EBIT is CN¥249.1M making its interest coverage ratio 3.6. It has cash and short-term investments of CN¥909.5M.
Key information
69.5%
Debt to equity ratio
CN¥2.80b
Debt
| Interest coverage ratio | 3.6x |
| Cash | CN¥909.45m |
| Equity | CN¥4.03b |
| Total liabilities | CN¥5.12b |
| Total assets | CN¥9.15b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600789's short term assets (CN¥4.2B) exceed its short term liabilities (CN¥3.5B).
Long Term Liabilities: 600789's short term assets (CN¥4.2B) exceed its long term liabilities (CN¥1.6B).
Debt to Equity History and Analysis
Debt Level: 600789's net debt to equity ratio (46.9%) is considered high.
Reducing Debt: 600789's debt to equity ratio has increased from 58.6% to 69.5% over the past 5 years.
Debt Coverage: 600789's debt is not well covered by operating cash flow (19.6%).
Interest Coverage: 600789's interest payments on its debt are well covered by EBIT (3.6x coverage).